Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OSCR Stock Forecast 2026-2027
$16.17
Current Price
$4.81B
Market Cap
Buy 2
Hold 5
Sell 3
Wall St Analyst Ratings
Distance to OSCR Price Targets
+42.2%
To High Target of $23.00
-1.1%
To Median Target of $16.00
-38.2%
To Low Target of $10.00
OSCR Price Momentum
+3.7%
1 Week Change
+28.0%
1 Month Change
+39.4%
1 Year Change
+12.5%
Year-to-Date Change
-32.1%
From 52W High of $23.80
+51.3%
From 52W Low of $10.69
📊 TOP ANALYST CALLS
Did OSCR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Oscar Health is one of their latest high-conviction picks.
Latest OSCR Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, OSCR has a neutral consensus with a median price target of $16.00 (ranging from $10.00 to $23.00). The overall analyst rating is Hold (5.4/10). Currently trading at $16.17, the median forecast implies a -1.1% downside. This outlook is supported by 2 Buy, 5 Hold, and 3 Sell ratings.
The most optimistic forecast comes from Jonathan Yong at UBS, projecting a 42.2% upside. Conversely, the most conservative target is provided by Stephen Baxter at Wells Fargo, suggesting a 38.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OSCR Analyst Ratings
2
Buy
5
Hold
3
Sell
OSCR Price Target Range
Low
$10.00
Average
$16.00
High
$23.00
Current: $16.17
Latest OSCR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OSCR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 20, 2026 | Jefferies | David Windley | Hold | Upgrade | $16.00 |
| Jan 9, 2026 | UBS | Jonathan Yong | Neutral | Upgrade | $17.00 |
| Jan 5, 2026 | Barclays | Andrew Mok | Equal-Weight | Upgrade | $18.00 |
| Dec 11, 2025 | Stephens & Co. | Dean Sublett | Equal-Weight | Initiates | $17.00 |
| Nov 26, 2025 | Piper Sandler | Jessica Tassan | Overweight | Upgrade | $25.00 |
| Nov 13, 2025 | Wells Fargo | Stephen Baxter | Underweight | Maintains | $11.00 |
| Nov 10, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $13.00 |
| Nov 7, 2025 | UBS | Jonathan Yong | Sell | Maintains | $12.00 |
| Oct 14, 2025 | Goldman Sachs | Scott Fidel | Neutral | Initiates | $17.00 |
| Oct 7, 2025 | Wells Fargo | Stephen Baxter | Underweight | Maintains | $14.00 |
| Aug 14, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $13.00 |
| Jul 25, 2025 | Baird | Michael Ha | Neutral | Downgrade | $14.00 |
| Jul 23, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $11.00 |
| Jul 15, 2025 | UBS | Jonathan Yong | Sell | Downgrade | $11.00 |
| Jul 11, 2025 | Wells Fargo | Stephen Baxter | Underweight | Downgrade | $10.00 |
| Jul 2, 2025 | Barclays | Andrew Mok | Underweight | Initiates | $17.00 |
| Jun 9, 2025 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $18.00 |
| Mar 13, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Downgrade | $16.00 |
| Dec 10, 2024 | Jefferies | David Windley | Underperform | Initiates | $12.00 |
| Nov 6, 2024 | B of A Securities | Adam Ron | Underperform | Downgrade | $13.50 |
Oscar Health, Inc. (OSCR) Competitors
The following stocks are similar to Oscar Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Oscar Health, Inc. (OSCR) Financial Data
Oscar Health, Inc. has a market capitalization of $4.81B with a P/E ratio of 34.6x. The company generates $11.70B in trailing twelve-month revenue with a -3.8% profit margin.
Revenue growth is +17.3% quarter-over-quarter, while maintaining an operating margin of -11.9% and return on equity of -44.4%.
Valuation Metrics
Market Cap
$4.81B
Enterprise Value
$1.21B
P/E Ratio
34.6x
PEG Ratio
0.3x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+17.3%
Gross Margin
N/A
Operating Margin
-11.9%
Net Margin
-3.8%
EPS Growth
+17.2%
Financial Health
Cash/Price Ratio
+83.0%
Current Ratio
0.9x
Debt/Equity
50.9x
ROE
-44.4%
ROA
-4.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Oscar Health, Inc. (OSCR) Business Model
About Oscar Health, Inc.
What They Do
Provides technology-driven health insurance solutions.
Business Model
Oscar Health makes money by offering health insurance plans to individuals, families, and small groups, both on and off the exchange. The company uses a proprietary digital platform to streamline enrollment, claims processing, and member support, enhancing user experience and operational efficiency.
Additional Information
Founded in 2012 and headquartered in New York, Oscar Health also licenses its technology platform to other healthcare providers and payers, contributing to its revenue. The company focuses on compliance with the Affordable Care Act and offers Medicare Advantage plans, positioning itself as a modern player in the health insurance market.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
2,305
CEO
Mr. Mark Thomas Bertolini
Country
United States
IPO Year
2021
Website
www.hioscar.comOscar Health, Inc. (OSCR) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $16.17, denoting a -1.64% move from the preceding trading day.
Apr 21, 2026
By Zacks Equity Research
Tale of the Tape
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $15.29, denoting a -1.23% move from the preceding trading day.
Apr 14, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Should You Buy Oscar Health Stock Today?
7 days ago
Quick Summary
Oscar Health (OSCR) stock is seeing increased momentum as investor sentiment towards the industry improves.
Why It Matters
Oscar Health's rising stock indicates improved investor sentiment, potentially signaling a turnaround in the health insurance sector, which could lead to increased investment and market confidence.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Oscar Health, Inc. (OSCR) closed at $15.29, reflecting a decline of 1.23% from the previous trading day.
Why It Matters
The decline in Oscar Health's stock price indicates potential investor concerns about the company's performance or market conditions, influencing sentiment and trading strategies.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Healthcare stocks are currently undervalued, with UnitedHealth seen as a strong buy opportunity, expected to rebound soon.
Why It Matters
Beaten-down healthcare stocks, like UnitedHealth, may offer long-term value, indicating potential for recovery and profit opportunities for investors.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Peter Lynch stated that while insiders may sell stock for various reasons, they buy shares solely when they believe the stock price will increase.
Why It Matters
Insider buying signals confidence in a company's future performance, potentially indicating undervaluation and a bullish outlook, influencing investment decisions positively.
Source: 24/7 Wall Street
Market Sentiment:
Neutral
Quick Summary
Bertolini's filing revealed 5.73 million performance stock units vested, with over 1 million shares withheld for taxes; indicates a company stock purchase.
Why It Matters
Bertolini's stock units vesting and the company's buyback signal confidence in future performance, potentially boosting stock value and attracting investor interest.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
Oscar Health maintains a "Buy" rating despite a 7% stock decline. Management's 61% growth guidance and CEO insider buying support positive outlook and potential price recovery.
Why It Matters
Oscar Health's strong growth guidance and CEO insider buying signal confidence in future performance, potentially driving stock recovery and valuation increase, despite recent declines.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About OSCR Stock
What is Oscar Health, Inc.'s (OSCR) stock forecast for 2026?
Based on our analysis of 16 Wall Street analysts, Oscar Health, Inc. (OSCR) has a median price target of $16.00. The highest price target is $23.00 and the lowest is $10.00.
Is OSCR stock a good investment in 2026?
According to current analyst ratings, OSCR has 2 Buy ratings, 5 Hold ratings, and 3 Sell ratings. The stock is currently trading at $16.17. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OSCR stock?
Wall Street analysts predict OSCR stock could reach $16.00 in the next 12 months. This represents a -1.1% decrease from the current price of $16.17. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Oscar Health, Inc.'s business model?
Oscar Health makes money by offering health insurance plans to individuals, families, and small groups, both on and off the exchange. The company uses a proprietary digital platform to streamline enrollment, claims processing, and member support, enhancing user experience and operational efficiency.
What is the highest forecasted price for OSCR Oscar Health, Inc.?
The highest price target for OSCR is $23.00 from Jonathan Yong at UBS, which represents a 42.2% increase from the current price of $16.17.
What is the lowest forecasted price for OSCR Oscar Health, Inc.?
The lowest price target for OSCR is $10.00 from Stephen Baxter at Wells Fargo, which represents a -38.2% decrease from the current price of $16.17.
What is the overall OSCR consensus from analysts for Oscar Health, Inc.?
The overall analyst consensus for OSCR is neutral. Out of 16 Wall Street analysts, 2 rate it as Buy, 5 as Hold, and 3 as Sell, with a median price target of $16.00.
How accurate are OSCR stock price projections?
Stock price projections, including those for Oscar Health, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 3:32 AM UTC